Software iterative lifecycle

In order to better safeguard the rights of our customers and to ensure the security, stability and reliability of our products, LinkZill has formulated a policy on the security update cycle of our products to ensure that our customers receive continuous support and satisfactory service during the security update cycle of our products.

Product Name Product Model Software Version Security Period Start Date Security Period End Date
TruEbox 01RC LZ-01ARC (M) V1.1.2 2022.06.10 2025.06.10
TruEbox 02CM LZ-02ACM (M) V2.1.0 2022.06.09 2025.06.09
TruEbox TFT-IV LZ-TFT-IV (S) V2.1.0 2022.10.13 2025.10.13
TruEbox 03MR (64×64) LZ-03AMR (64*64) V2.0.1 2023.01.09 2025.01.09
TruEbox 03MR (256×256) LZ-03AMR (256*256) V2.0.0 2024.06.26 2026.06.26
TruEbox 04MD (256×256) LZ-04AMD (256*256) V1.0.0 2023.07.28 2025.07.28

Support Period Start Date: The date on which security updates began to be provided for this product

Support Period End Date: The date on which security updates and services are no longer available for the product

We will manage vulnerabilities for product versions prior to the security update expiration date, and patch high security level vulnerabilities after the expiration date as appropriate.

To protect our customers,LinkZill wil provide at least 2 years of security update support for our products. The support period will not be shortened after publication. lf the defined support period is extended, we will update the lists above as soon as possible to help you check whether your device can still receive security updates.

If you have any questions about this policy, please contact LinkZill (info@linkzill.com).

Dr. Kang Kang

Partner & CBio

Dr. Kang received his Ph.D. in Bioinformatics and Systems Biology from the University of Hong Kong in 2018, then became a scientific co-worker of the Leibniz Association (Leibniz-HKI) and a visiting scientist at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at the Technical University of Denmark. He was a scientist at BGI-Shenzhen and co-founded the synthetic biology research group. He was a senior bioinformatics engineer and brand advisor at WeGene. In 2021, Kang joined Biosysen Limited as a co-founder and served as Chief Informatics Scientist. He is also an advisor and author of the biotech media "Regenesis". He has been dedicated to the R&D and industrialization of OMICs technologies, high-throughput technologies, and synthetic biology for over 10 years. He joined LinkZill in March 2023, responsible for semiconductor life science tools and product planning.

康康   博士

合伙人兼首席生物信息官

博士毕业于香港大学生物信息和系统生物学专业,后任德国莱布尼茨协会科学合作者、丹麦科技大学诺和诺德生物可持续研究中心访问科学家。曾先后担任华大基因科学家,参与创立了华大基因合成生物学研究方向;微基因资深生物信息工程师、品牌顾问;倍生生物联合创始人兼首席信息科学家。他专注于合成生物学、组学和高通量技术10余年,同时也是生物技术领域颇具影响力的「行业KOL」。2023年3月加入领挚科技,负责半导体生命科学工具方向与产品规划。